TITLE

A seizure with a spot: a study of patients with mesial temporal lobe epilepsy

AUTHOR(S)
Sundarachary, N. V.; Sridhar, A.
PUB. DATE
April 2015
SOURCE
Journal of Clinical & Scientific Research;Apr-Jun2015, Vol. 4 Issue 2, p248
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents a case study of men with an average age of 24.5 years with mesial temporal lobe epilepsy (MTLE) who were treated with amygadalo hippocampectomy and recovered following a antiepileptic drug therapy.
ACCESSION #
111478776

 

Related Articles

  • Extra-temporal Epilepsy, Surgical Possibilities: a Case Study.  // American Journal of Electroneurodiagnostic Technology;Mar2004, Vol. 44 Issue 1, p47 

    Presents a case study of the surgical possibilities for patients with extra-temporal lobe epilepsy. Background on the ineffectiveness of drugs in treating the disease; Approximate number of patients suffering from epilepsy in the Netherlands.

  • A seizure with a spot: a study of patients with mesial temporal lobe epilepsy. Sundarachary, N. V.; Sridhar, A. // Journal of Clinical & Scientific Research;Jul-Sep2015, Vol. 4 Issue 3, p248 

    The article presents a case study of men with an average age of 24.5 years with mesial temporal lobe epilepsy (MTLE) who were treated with amygadalo hippocampectomy and recovered following a antiepileptic drug therapy.

  • Seizure control resulting from intrahippocampal depth electrode insertion. Schulze-Bonhage, A.; Dennig, D.; Wagner, K.; Cordeiro, J.; Carius, A.; Fauser, S.; Trippel, M. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2010, Vol. 81 Issue 3, p352 

    The article presents a case study of a 37-year-old woman with a history of focal epileptic seizures. The patient underwent presurgical evaluation and underwent stereotactic implantation of depth electrode due to suspected left temporal lobe epilepsy. Her left temporal lobe epilepsy gradually...

  • Expression of HIF-1α and MDR1/P-glycoprotein in refractory mesial temporal lobe epilepsy patients and pharmacoresistant temporal lobe epilepsy rat model kindled by coriaria lactone. Li, Yaohua; Chen, Jianbin; Zeng, Tianfang; Lei, Ding; Chen, Lei; Zhou, Dong // Neurological Sciences;Aug2014, Vol. 35 Issue 8, p1203 

    Hypoxia-inducible factor-1α (HIF-1α) is thought to mediate pharmacoresistance in tumor by inducing Pgp overexpression. We aimed to investigate the expression of HIF-1α and MDR1/P-glycoprotein in refractory epilepsy, to explore the correlation of HIF-1α with epilepsy multidrug...

  • Epileptogenesis Beyond the Hippocampus. Stafstrom, Carl E. // Epilepsy Currents;Mar2003, Vol. 3 Issue 2, p66 

    Discusses research being done on temporal lobe epilepsy. Reference to a study by I. Cohen et al, published in a 2002 issue of 'Science'; Role of anticonvulsant drugs.

  • Herbs and Spices: Unexpected Sources of Antiepileptogenic Drug Treatments? Wong, Michael // Epilepsy Currents;Jan/Feb2010, Vol. 10 Issue 1, p21 

    Resveratrol (Res) is a phytoalexin produced naturally by several plants, which has multifunctional effects such as neuroprotection, anti-inflammatory, and anti-cancer. The present study was to evaluate a possible anti-epileptic effect of Res against kainate-induced temporal lobe epilepsy (TLE)...

  • Treatment of Refractory Mesial Temporal Lobe Epilepsy. Kieling, Renata R.; Palmini, André; Paglioli, Eliseu; Gomez-Alonso, Juan; Engel J., Jerome; McDermott, Michael P.; Langfitt, John T. // JAMA: Journal of the American Medical Association;6/20/2012, Vol. 307 Issue 23, p2483 

    Several letters to the editor related to the superiority of surgical therapy over antiepileptic drugs in the treatment of refractory mesial temporal lobe epilepsy and a response by the editor to the same are presented.

  • RESISTANT EPILEPSY - CASE PRESENTATION. Roceanu, A.; Mindruta, I.; Ichim, B.; Onescu, I.; Bajenaru, O. // Romanian Journal of Neurology;Aug2010, Vol. 9 Issue 3, p156 

    Pharmacoresistant epilepsy is defined as the persistence of seizures despite adequate use of antiepileptic drugs, with a minimum of two first-line drugs either as monotherapy or in combination as appropriate to the epileptic syndrome. We present the case of a 31-year-old male, with...

  • Selective Amygdalohippocampectomy. Spencer, David; Burchiel, Kim // Epilepsy Research & Treatment;2012, p1 

    Epilepsy surgery can be an effective epilepsy treatment for patients whose seizures do not respond to best medical therapy. For patients with temporal lobe epilepsy, selective amygdalohippocampectomy (SAH) has emerged as a viable alternative to standard anterior temporal lobectomy. This paper...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics